Literature DB >> 25444899

Skin cancer and new treatment perspectives: a review.

M C F Simões1, J J S Sousa2, A A C C Pais3.   

Abstract

Skin cancers are by far the most common malignancy of humans, particularly in the white population. The growing incidence of cutaneous malignancies has heralded the need for multiple treatment options. Although surgical modalities remain the mainstay of treatment, new research and fresh innovation are still required to reduce morbidity and mortality. Approaches for skin cancer may pass through new technological methods instead of new molecules. The first part of this paper provides a review of the state of the art regarding skin cancer disease as well as epidemiology data. Then, it describes the gold standards of the current recommended therapies worldwide and the actual needs of these patients. This is the first paper that highlights the novel and future therapeutic perspectives for the treatment of skin malignancies, new therapeutic agents and promising technological approaches, from nanotechnology to immunotherapy.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Immunotherapy; Nanoparticles; Phototherapy; Polymers; Skin cancer

Mesh:

Year:  2014        PMID: 25444899     DOI: 10.1016/j.canlet.2014.11.001

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  43 in total

1.  Inhibition of mTORC2 enhances UVB-induced apoptosis in keratinocytes through a mechanism dependent on the FOXO3a transcriptional target NOXA but independent of TRAIL.

Authors:  Robert P Feehan; Amanda M Nelson; Lisa M Shantz
Journal:  Cell Signal       Date:  2018-08-30       Impact factor: 4.315

2.  Ethanol extract of Ilex hainanensis Merr. exhibits anti-melanoma activity by induction of G1/S cell-cycle arrest and apoptosis.

Authors:  Ya-Qi Zhang; Hao Yang; Wei-Dong Sun; Juan Wang; Bao-Yuan Zhang; Yan-Jun Shen; Min-Qiang Yin; Yun-Xing Liu; Chang Liu; Yun Sun
Journal:  Chin J Integr Med       Date:  2017-07-25       Impact factor: 1.978

Review 3.  Cancer Stem Cells: Acquisition, Characteristics, Therapeutic Implications, Targeting Strategies and Future Prospects.

Authors:  Anoop K Yadav; Neetin S Desai
Journal:  Stem Cell Rev Rep       Date:  2019-06       Impact factor: 5.739

Review 4.  The circadian clock and diseases of the skin.

Authors:  Junyan Duan; Elyse Noelani Greenberg; Satya Swaroop Karri; Bogi Andersen
Journal:  FEBS Lett       Date:  2021-09-29       Impact factor: 3.864

5.  A comparative study: the prospective influence of nanovectors in leveraging the chemopreventive potential of COX-2 inhibitors against skin cancer.

Authors:  Noha Khalifa Abo Aasy; Doaa Ragab; Marwa Ahmed Sallam; Doaa A Abdelmonsif; Rania G Aly; Kadria A Elkhodairy
Journal:  Int J Nanomedicine       Date:  2019-09-17

Review 6.  DHODH and cancer: promising prospects to be explored.

Authors:  Yue Zhou; Lei Tao; Xia Zhou; Zeping Zuo; Jin Gong; Xiaocong Liu; Yang Zhou; Chunqi Liu; Na Sang; Huan Liu; Jiao Zou; Kun Gou; Xiaowei Yang; Yinglan Zhao
Journal:  Cancer Metab       Date:  2021-05-10

Review 7.  Diet phytochemicals and cutaneous carcinoma chemoprevention: A review.

Authors:  Siliang Wang; Peiliang Shen; Jinrong Zhou; Yin Lu
Journal:  Pharmacol Res       Date:  2017-02-24       Impact factor: 10.334

8.  Novel UV filters from Pentacalia pulchella extracts with photoprotective properties and antioxidant activity.

Authors:  Juan C Mejía-Giraldo; Robert Winkler; Miguel Puertas-Mejía
Journal:  Photochem Photobiol Sci       Date:  2021-11-01       Impact factor: 3.982

Review 9.  Advances in the in Vivo Raman Spectroscopy of Malignant Skin Tumors Using Portable Instrumentation.

Authors:  Nikolaos Kourkoumelis; Ioannis Balatsoukas; Violetta Moulia; Aspasia Elka; Georgios Gaitanis; Ioannis D Bassukas
Journal:  Int J Mol Sci       Date:  2015-06-26       Impact factor: 5.923

Review 10.  Drug delivery strategies for chemoprevention of UVB-induced skin cancer: A review.

Authors:  Arvind Bagde; Arindam Mondal; Mandip Singh
Journal:  Photodermatol Photoimmunol Photomed       Date:  2018-01       Impact factor: 3.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.